HomeNewsCricket NewsIPL 2021Star India may have to suffer a huge hit on IPL 2021 suspension; experts estimate around Rs 2,000 crore loss

Star India may have to suffer a huge hit on IPL 2021 suspension; experts estimate around Rs 2,000 crore loss

With the BCCI suspending IPL 14 midway, Star India will not get any revenue from the ads booked for the remaining matches. The ad rates for playoffs are higher than initial matches, and Star India charges a 10-15 percent premium for the last few matches in IPL.

May 04, 2021 / 16:59 IST
Story continues below Advertisement
Organisers of the 2021 edition of the Indian Premier League have announced the suspension of the League with immediate effect. This comes amidst the rise of the COVID-19 cases within the teams in just the past few days.
Organisers of the 2021 edition of the Indian Premier League have announced the suspension of the League with immediate effect. This comes amidst the rise of the COVID-19 cases within the teams in just the past few days.

The Indian Premier League Governing Council (IPL GC) and the Board of Control for Cricket in India (BCCI), in an emergency meeting, has unanimously decided to postpone IPL 2021 season, with immediate effect.

The season, being hosted in six cities, started on April 9 and would have ended on May 30.

Story continues below Advertisement

IPL 14’s suspension will mean huge losses for Star India, the official broadcaster.

According to Sandeep Goyal, Mogae Media, a Mumbai-based marketing and communication agency, the league is halfway through. IPL 14 getting delayed now will lead to Star India suffering a 60 percent loss in advertisement revenue.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show